Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Justin L. Hay
The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia
Oncologist
Cancer Research
Medicine
Oncology
Related publications
High CD33-antigen Loads in Peripheral Blood Limit the Efficacy of Gemtuzumab Ozogamicin (Mylotarg®) Treatment in Acute Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Analysis of Factors That Affect in Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in Acute Myeloid Leukaemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Clinical Cancer Research
Cancer Research
Oncology
High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902
Leukemia Research
Cancer Research
Oncology
Hematology
Gemtuzumab Ozogamicin in Children With Relapsed or Refractory Acute Myeloid Leukemia: A Report of Berlin-Frankfurt-Münster Study Group
Haematologica
Hematology
Preliminary Results of the Safety of Immunotherapy With Gemtuzumab Ozogamicin Following Reduced Intensity Allogeneic Stem Cell Transplant in Children With CD33+ Acute Myeloid Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Frontiers in Medicine
Medicine
Molecular Emergence of Acute Myeloid Leukemia During Treatment for Acute Lymphoblastic Leukemia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
